These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18227733)

  • 41. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
    Karam JA; Lotan Y; Karakiewicz PI; Ashfaq R; Sagalowsky AI; Roehrborn CG; Shariat SF
    Lancet Oncol; 2007 Feb; 8(2):128-36. PubMed ID: 17267327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
    Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
    Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin.
    Dogu GG; Ozkan M; Ozturk F; Dikilitas M; Er O; Ozturk A
    Med Oncol; 2010 Mar; 27(1):34-9. PubMed ID: 19156550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a).
    Kayaselcuk F; Nursal TZ; Polat A; Noyan T; Yildirim S; Tarim A; Seydaoglu G
    J Exp Clin Cancer Res; 2004 Mar; 23(1):105-12. PubMed ID: 15149158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum her-2/neu and survivin levels and their relationship to histological parameters in early-stage breast cancer.
    Goksel G; Taneli F; Uslu R; Ulman C; Dinc G; Coskun T; Kandiloglu AR
    J Int Med Res; 2007; 35(2):165-72. PubMed ID: 17542404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
    Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
    Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
    Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression and prognostic significance of survivin and caspase-3 in esophageal squamous-cell carcinoma and their relationship with HSPs expression].
    Cao FM; Zhang XH; Yan X; Wang JL; Xing LX; Wang XL; Shen HT; Wang FR
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):416-9. PubMed ID: 16188127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.
    Pu X; Storr SJ; Zhang Y; Rakha EA; Green AR; Ellis IO; Martin SG
    Apoptosis; 2017 Mar; 22(3):357-368. PubMed ID: 27798717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
    Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
    Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
    Byun SS; Yeo WG; Lee SE; Lee E
    Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survivin expression and targeting in breast cancer.
    Jha K; Shukla M; Pandey M
    Surg Oncol; 2012 Jun; 21(2):125-31. PubMed ID: 21334875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
    Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.